Steven Zourabian, DO
Orthopaedic Trauma · Castro Valley, CANPI 1578918926
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $13,095 with a category attached, or 76.4%. Arthrex accounts for 76.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $11,207 and has fallen 98.7% since, to $151 in 2025.
Across 30 payments — averaging $436.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Synthes GmbH$1K
- Johnson & Johnson$765
- Sequoia Surgical, Inc.$718
- Stryker$152
- Smith+Nephew$138
- plus $278 from 6 others
What the payments were for
- Grants$10,00076%
- Travel & lodging$1,0468%
- Food & beverage$1,36810%
- Education$6825%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $10,000 |
| Synthes GmbH | 2 | $1,046 |
| Johnson & Johnson | 9 | $765 |
| Sequoia Surgical, Inc. | 3 | $718 |
| Stryker | 2 | $152 |
| Smith+Nephew | 4 | $138 |
| Medical Device Business Services, Inc. | 3 | $68 |
| Paragon 28, Inc. | 1 | $61 |
| Orthofix Medical, Inc. | 2 | $59 |
| Globus Medical | 1 | $36 |
| Organogenesis Inc. | 1 | $31 |
| Acera Surgical, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$956
- MOTOBAND$591
- HAMMERLOCK$224
- Fibulink$109
- MOTOBAND CP$109
- GAMMA$103
How this compares
$13,095 in reported general payments places this provider in the 55th percentile of 106 orthopaedic trauma providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Castro Valley
- Michael GardnerStanford$2.9M
- Aaron OsborneRedding$1.3M
- Robert Tonksla Jolla$1.3M
- John ScolaroOrange$1M
- David LowenbergSan Francisco$788K
- Eric LindvallClovis$609K
- Christopher LeeLos Angeles$475K
- Joshua GaryLos Angeles$466K
- Christopher HoshinoTorrance$356K
- Julius BishopStanford$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.